Drug Retail

J.P. Morgan is out with its report today on CVS Caremark (NYSE: CVS), maintaining Overweight. In a note to clients, J.P. Morgan writes, "Our rating on CVS Caremark is Overweight. We are a believer in the integrated PBM-retail pharmacy model, and believe the company should gain traction in the...

As part of CVS Caremark (NYSE: CVS) Week, J.P. Morgan is discussing the company's “integrated offering.” “Given its unique position, the company has been able to develop unique programs to lower costs and improve outcomes,” J.P. Morgan writes. “Programs such as Maintenance Choice have had a...

JP Morgan commented on CVS Caremark (NYSE: CVS) in a report released today. In the report, JP Morgan was positive in its assessment of the company. JP Morgan writes, "The company has guided to an impressive target of $5.5-$6.5B in average annual cash available for enhancing shareholder value,...

Shares of Walgreens Company (NYSE: WAG) fell about 0.2% after the company reported a 5.6% rise in its May same-store sales. Walgreens total May sales jumped 7% to $6.08 billion. Analysts were expecting same-store sales to increase 4.9%. Walgreens' total front-end sales surged 5.5% in May, while...

Walgreens Company (NYSE: WAG) reported a 5.6% rise in its May same-store sales on Friday. Walgreens total May sales jumped 7% to $6.08 billion. Analysts were expecting same-store sales to increase 4.9%. Walgreens' total front-end sales surged 5.5% in May, while comparable store front-end sales...

Some of the stocks that may grab investor focus today are: Diamond Foods Inc (NASDAQ: DMND) swung to a Q3 profit and lifted its projections for the year. DMND reported its quarterly profit at $7.7 million, or $0.34 per share, versus a loss of $4.3 million, or $0.22 per share, in the year-earlier...

Costco Wholesale Corp (NASDAQ: COST) reported a 13% rise in its May comparable-store sales on Thursday. The retailer's net sales surged 17% to $7.14 billion, from $6.09 billion in the year-ago month. However, analysts expected same-store sales to rise 11.2% for the month. Its same-store sales...

CNBC Fast Money's Brian Kelly said on the show that you can stay long iShares Barclays 20+ Year Treasury Bond (ETF) (NYSE: TLT). He thinks that it will go to $100. iShares Barclays 20+ Year Treasury Bond (ETF) (TLT) gained 0.98% today, and it closed at $97.64. Mike Khouw thinks that you still have...

Cusick's Corner To say that this was an ugly close is an understatement. Now here's the good and the bad. The good is that the day is over (especially if you were long). The bad is that the market was down (300 on the Dow). This was a solid distribution day with a close below the lows of yesterday...

Shares of CVS Caremark Corporation (NYSE: CVS) are lower on the session by 0.53%, trading at $38.48. Overall put volume is now running at 2.37x the daily average, with 7% of all puts traded being purchases on the offer. 9,001 contracts have traded on the session so far. CVS Caremark Corporation...

On CNBC's Fast Money, Tim Seymour advised investors to stay with The Mosaic Company (NYSE: MOS). The Mosaic Company (MOS) gained 1.16% today, and it closed at $70.85. Guy Adami likes CVS Caremark Corporation (NYSE: CVS), and wants to buy it tomorrow. CVS Caremark Corporation (CVS) fell 0.28% today...

Shares of Rite Aid Corporation (NYSE: RAD) are lower on the session by 1.89%, currently trading at $1.04. The stock has been moving largely lower over the past four months and is currently trading below the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A...

Nokia (NOK) Lowers Devices & Services Second Quarter 2011 Outlook And Updates Full Year 2011 Outlook Yongve International (YONG) (CVS) CVS and Medco stocks could provide 'healthy' returns, Barron's says Funtalk China Holdings Ltd. (FTLK) Funtalk China Holdings Limited Enters Into Definitive...

J.P. Morgan is out with its report today on CVS Caremark (NYSE: CVS), raising its PT from $42 to $43. In a note to clients, J.P. Morgan writes, "In our view, the FEP mail contract win is a significant positive for the company's PBM business. While we estimate the contract could add ~2% to EPS,...

Citigroup has raised the price target on CVS Caremark (NYSE: CVS) from $41 to $46 and maintains its Buy rating.